United States · FDA National Drug Code directory
CARBOPLATIN
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 82511-005_2b3f8994-659d-b905-e063-6394a90a3aec
- Product NDC
- 82511-005
- Form
- INJECTION, SOLUTION
- Composition / generic term
- CARBOPLATIN
- Labeler
- Teyro Labs Private Limited
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20070118
- Source listing expiry
- 20261231
Source-listed ingredients
- CARBOPLATIN — 450 mg/45mL
These values do not establish equivalence or a dose recommendation.
Packages
- 1 VIAL, MULTI-DOSE in 1 CARTON (82511-005-45) / 45 mL in 1 VIAL, MULTI-DOSE · 82511-005-45
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →